Cornerstone Planning Group LLC Blueprint Medicines Corp Transaction History
Cornerstone Planning Group LLC
- $418 Billion
- Q1 2025
A detailed history of Cornerstone Planning Group LLC transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Cornerstone Planning Group LLC holds 9 shares of BPMC stock, worth $916. This represents 0.0% of its overall portfolio holdings.
Number of Shares
9Holding current value
$916% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding BPMC
# of Institutions
394Shares Held
60.4MCall Options Held
1.6MPut Options Held
1.41M-
Black Rock Inc. New York, NY6.65MShares$677 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.64MShares$676 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.68MShares$578 Million0.06% of portfolio
-
Jpmorgan Chase & CO New York, NY2.51MShares$255 Million0.02% of portfolio
-
State Street Corp Boston, MA2.5MShares$255 Million0.01% of portfolio
About Blueprint Medicines Corp
- Ticker BPMC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,719,600
- Market Cap $6.08B
- Description
- Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...